Sign in
4/A

Changes in Ownership

Protara Therapeutics, Inc. Filed Acc 0001209191-20-035845

Options or other derivatives

  • Director acquired 34,716 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Braunstein Scott Director 2020-01-09 Grant or award · Stock Option (Right to Buy) +2,861 2,861 D: show line 1 in the form
Braunstein Scott Director 2020-01-09 Grant or award · Stock Option (Right to Buy) +16,214 16,214 D: show line 2 in the form
Braunstein Scott Director 2020-01-09 Grant or award · Stock Option (Right to Buy) +15,641 15,641 D: show line 3 in the form
Loading xslF345X03/doc4a.xml…